NCT05085340 MULTIple Doses of IPTi Proposal: a Lifesaving High Yield Intervention Status COMPLETED Phase N/A
NCT05084651 Drug-drug Interaction Study of Ganaplacide and Lumefantrine With Itraconazole Status COMPLETED Phase PHASE1
NCT05070520 Efficacy of Antimalarial Drugs Used for the Treatment of Uncomplicated Malaria, Plasmodium Falciparum, at the Agadez, Gaya and Tessaoua Sentinel Sites Status COMPLETED Phase PHASE4
NCT05050825 Validation of a CDSA Strategy to Reduce Antibiotic Prescription in Senegal Status UNKNOWN Phase NA
NCT05041556 Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine Status RECRUITING Phase N/A
NCT04978272 Modifying Immunity in Children With DihydROartemisinin-Piperaquine (MIC-DroP) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04969913 Community Dynamics of Malaria Transmission in Humans and Mosquitoes at Maferinyah Sub-Prefecture, Guinea Status COMPLETED Phase N/A
NCT04966871 Safety, Tolerability and Efficacy of PfSPZ Vaccine Against Heterologous CHMI in US Malaria naïve Adults Status COMPLETED Phase PHASE1
NCT04966702 Broad One Health Endectocide-based Malaria Intervention in Africa (BOHEMIA) Status COMPLETED Phase PHASE3
NCT04944966 Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria Status COMPLETED Phase PHASE2
NCT04897919 Effectiveness and Safety of Artemether + Lumefantrine and Dihydroartemisinin + Piperaquine for Treating Malaria Status COMPLETED Phase PHASE4
NCT04864444 Mass Drug Administration of Dihydroartemisinin-piperaquine + Single Low-dose Primaquine to Accelerate Toward Elimination Activities Status COMPLETED Phase NA
NCT04858087 Malawi International Center of Excellence in Malaria Research School-based Cohort Status COMPLETED Phase N/A
NCT04844099 Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia Status COMPLETED Phase PHASE3